Milbemycin α25 was a generous gift from Daiichi Sankyo Co., Ltd. (Tokyo, Japan). FK506 was kindly provided by Astellas Pharma Inc. (Tokyo, Japan). FLC was purchased from LKT Laboratories Inc. (St. Paul, MN). Clotrimazole (CLT), miconazole (MCZ), ketoconazole (KTC), itraconazole (ITC), voriconazole (VRC), posaconazole (PSC), nigericin (NIG), monensin (MON), latrunculin A (LaA), cerulenin (CER), rhodamine 6G (R6G), beauvericin, and amphotericin B (AMB) were obtained from Sigma-Aldrich Japan Inc. (Tokyo, Japan). Enniatin B was purchased from Alexis Biochemicals (San Diego, CA). Cycloheximide (CHX) was purchased from Nacalai Tesque Inc. (Kyoto, Japan). RC21v3 was our in-house-developed d-octapeptide Candia albicans Cdr1-specific inhibitor (23 (link)).
Free full text: Click here